Vitrolife
VITR | ST
Overview
Corporate Details
- ISIN(s):
- SE0011205202 (+1 more)
- LEI:
- 5493001WDZMONMSPPR49
- Country:
- Sweden
- Address:
- Box 9080, 400 92 Göteborg
- Website:
- https://www.vitrolife.com/
- Sector:
- Health Care
- Industry:
- Health Care Equipment & Supplies
Description
Vitrolife is committed to supporting successful treatment outcomes, through a focus on IVF and the needs of clinics and testing labs. We’ve been dedicated to IVF since 1994, when the field was still young. Today, we support customers worldwide - always with sustainability in mind. Vitrolife Group has approximately 1200 employees and the headquarter is located in Sweden with additional locations and production facilities in more than 20 countries world-wide. In 2021, Vitrolife acquired Igenomix which is a leader in reproductive genetic testing services for IVF clinics, founded in 2011. Together we create a global leader in reproductive health and by combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we will be able to better support clinics and patients across the fertility journey.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-04-30 09:09 |
Regulatory News Service
Kommuniké från årsstämma i Vitrolife AB (publ)
|
Swedish | 136.9 KB | |
2025-04-30 09:09 |
Regulatory News Service
Report from Annual General Meeting of Vitrolife AB (publ)
|
English | 137.2 KB | |
2025-04-29 16:56 |
Regulatory News Service
Kommuniké från årsstämma i Vitrolife AB (publ)
|
Swedish | 156.5 KB | |
2025-04-29 16:56 |
Regulatory News Service
Report from Annual General Meeting of Vitrolife AB (publ)
|
English | 160.1 KB | |
2025-04-24 08:00 |
Quarterly Report
|
Swedish | 2.1 MB | |
2025-04-24 08:00 |
Quarterly Report
|
English | 2.2 MB | |
2025-03-25 18:30 |
Regulatory News Service
Notice to attend the Annual General Meeting of Vitrolife AB (publ)
|
English | 386.7 KB | |
2025-03-25 18:30 |
Regulatory News Service
Kallelse till årsstämma i Vitrolife AB (publ)
|
Swedish | 328.4 KB | |
2025-02-21 13:00 |
Board/Management Change
Vitrolife Group utser Ermanno Sironi till Chief Operating Officer
|
Swedish | 132.2 KB | |
2025-02-21 13:00 |
Board/Management Change
The Vitrolife Group appoints Ermanno Sironi as Chief Operating Officer
|
English | 131.8 KB | |
2025-01-30 08:01 |
Annual Report
|
Swedish | 3.0 MB | |
2025-01-30 08:01 |
Quarterly Report
|
English | 3.0 MB | |
2024-10-24 08:01 |
Quarterly Report
|
Swedish | 3.0 MB | |
2024-10-24 08:01 |
Quarterly Report
|
English | 3.0 MB | |
2024-07-17 08:01 |
Interim Report
|
English | 2.7 MB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2023-04-26 | Patrik Tolf | Other | Buy | 2,500 | 535,045.25 SEK |
2023-02-02 | Ricardo Capella | Other | Buy | 3,000 | 739,200.00 SEK |
2022-10-31 | Patrik Tolf | Other | Buy | 3,000 | 537,000.00 SEK |
2022-09-28 | Ricardo Capella | Other | Buy | 3,000 | 484,800.00 SEK |
2021-09-06 | Mikael Engblom | Other | Sell | 700 | 359,100.00 SEK |
2021-09-06 | Mikael Engblom | Other | Sell | 538 | 274,380.00 SEK |
2021-09-06 | Mikael Engblom | Other | Sell | 500 | 257,500.00 SEK |
2021-09-06 | Mikael Engblom | Other | Sell | 500 | 256,000.00 SEK |
2021-09-06 | Mikael Engblom | Other | Sell | 490 | 249,410.00 SEK |
2021-09-06 | Mikael Engblom | Other | Sell | 482 | 245,820.00 SEK |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
4GLOBAL PLC | United Kingdom | 4GBL | |
![]() |
7 Fit Spolka Akcyjna | Poland | 7FT | |
![]() |
Acarix | Sweden | ACARIX | |
![]() |
Achiko AG | Switzerland | ACHI | |
![]() |
AcouSort AB | Sweden | ACOU | |
![]() |
ACUITY RM GROUP PLC | United Kingdom | ACRM | |
![]() |
ADDvise Group B | Sweden | ADDV | |
Advanced Medical Equipment Spolka Akcyjna | Poland | AME | ||
![]() |
Affluent Medical | France | AFME | |
![]() |
Airway Medix S.A. | Poland | AWM |